1. Home
  2. SNGX vs TKLF Comparison

SNGX vs TKLF Comparison

Compare SNGX & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.36

Market Cap

7.6M

Sector

Health Care

ML Signal

N/A

Logo Yoshitsu Co. Ltd

TKLF

Yoshitsu Co. Ltd

N/A

Current Price

$1.50

Market Cap

8.4M

ML Signal

N/A

Company Overview

Basic Information
Metric
SNGX
TKLF
Founded
1987
2006
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.4M
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
SNGX
TKLF
Price
$0.36
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 104.9K
12.4K
Earning Date
11-10-2026
12-18-2026
Dividend Yield
N/A
★ 15.56%
EPS Growth
★ 57.03
N/A
EPS
N/A
★ N/A
Revenue
★ $119,371.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$2.82
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$1.30
52 Week High
$3.39
$3.49

Technical Indicators

Market Signals
Indicator
SNGX
TKLF
Relative Strength Index (RSI) 36.40 40.18
Support Level $0.32 $1.30
Resistance Level $0.82 $1.63
Average True Range (ATR) 0.02 0.08
MACD 0.01 0.00
Stochastic Oscillator 64.02 15.25

Price Performance

Historical Comparison
SNGX
TKLF

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd is a retailer and wholesaler of Japanese beauty and health products, sundry products, electronic products, and other products. It sells its products through directly operated physical stores, online stores, and franchise stores and wholesale customers. It operates through directly operated physical stores, online stores and services, and franchise stores and wholesale customers segments, with the franchise stores and wholesale customers segment generating maximum revenue. Geographically, it generates maximum revenue from Hong Kong.

Share on Social Networks: